Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | F11 | P03951 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | CHUK | O15111 | 1/20 | 0.42 |
| ▸ | MAT2A | P31153 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.41 |
| ▸ | C5 | P01031 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21717474 | 0.89 | CHUK (0.50) | PARP1SMN1; SMN2CYP2A6LMNAF11 | |
| SCHEMBL21448261 | 0.89 | ALDH1A1 (0.50) | PARP1TP53SMN1; SMN2CYP2A6LMNA | |
| SCHEMBL30180882 | 0.89 | ALDH1A1 (0.50) | PARP1TP53SMN1; SMN2CYP2A6LMNA | |
| SCHEMBL21448386 | 0.87 | AHR (0.57) | SMN1; SMN2CYP2A6LMNAHPGDALDH1A1 | |
| SCHEMBL30180942 | 0.87 | AHR (0.57) | SMN1; SMN2CYP2A6LMNAHPGDALDH1A1 | |
| SCHEMBL30180806 | 0.87 | AHR (0.57) | SMN1; SMN2CYP2A6LMNAHPGDALDH1A1 | |
| SCHEMBL21448183 | 0.87 | AHR (0.57) | SMN1; SMN2CYP2A6LMNAHPGDALDH1A1 | |
| SCHEMBL2141394 | 0.83 | PARP1 (0.61) | PARP1TP53SMN1; SMN2LMNAHPGD | |
| SCHEMBL6009587 | 0.83 | PARP1 (0.65) | PARP1TP53SMN1; SMN2LMNAHPGD | |
| SCHEMBL31167250 | 0.83 | PARP1 (0.65) | PARP1TP53SMN1; SMN2LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12495717-B2 | Amine compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2025-12-09 | — | — | US | disclosed |
| US-20210057650-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| US-20210057650-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| WO-2019194617-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2019-10-10 | — | — | WO | disclosed |
| WO-2019194617-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2019-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12495717-B2 | Amine compound and organic light emitting diode comprising same | DRD1, RNF10, DRD2 | PARP1 3184/4885TP53 4217/4885SMN1; SMN2 1631/4885 |
| US-20210057650-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, RNF10, DRD2 | PARP1 3184/4885TP53 4217/4885SMN1; SMN2 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.